Palliative external beam radiotherapy for hepatocellular carcinoma with right atrial tumor thrombus.

[1]  A. D'Amico,et al.  Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer. , 2019, Journal of the American College of Cardiology.

[2]  Geoffrey D. Hugo,et al.  Phase I/II Trial of Electrophysiology-Guided Noninvasive Cardiac Radioablation for Ventricular Tachycardia , 2019, Circulation.

[3]  H. Nagano,et al.  Outcomes of surgery for hepatocellular carcinoma with tumor thrombus in the inferior vena cava or right atrium , 2018, Surgery Today.

[4]  Jeffrey W. Clark,et al.  Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor Genotype , 2017, Journal of the National Cancer Institute.

[5]  A. Grosu,et al.  Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma , 2017, Radiation oncology.

[6]  S. Jolly,et al.  Cardiac Events After Radiation Therapy: Combined Analysis of Prospective Multicenter Trials for Locally Advanced Non-Small-Cell Lung Cancer. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Yang Wang,et al.  HCC with tumor thrombus entering the right atrium and inferior vena cava treated by percutaneous ablation , 2017, BMC Surgery.

[8]  J. Bradley,et al.  Heart Dose Is an Independent Dosimetric Predictor of Overall Survival in Locally Advanced Non–Small Cell Lung Cancer , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[9]  M. Socinski,et al.  Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  P. Parikh,et al.  Stereotactic body radiotherapy for primary hepatic malignancies - Report of a phase I/II institutional study. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  Lipika Goyal,et al.  Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  J. Seong,et al.  Phase I dose-escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma , 2016, Oncotarget.

[13]  Ping Yang,et al.  High dose radiotherapy with image-guided hypo-IMRT for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombi is more feasible and efficacious than conventional 3D-CRT. , 2016, Japanese journal of clinical oncology.

[14]  Cynthia S. Johnson,et al.  Treatment variables related to liver toxicity in patients with hepatocellular carcinoma, Child-Pugh class A and B enrolled in a phase 1-2 trial of stereotactic body radiation therapy. , 2015, Practical radiation oncology.

[15]  Yan Wang,et al.  Trans-arterial chemoembolization and external beam radiation therapy for treatment of hepatocellular carcinoma with a tumor thrombus in the inferior vena cava and right atrium , 2015, Cancer Imaging.

[16]  H. Onishi,et al.  Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma , 2015, Journal of radiation research.

[17]  E. Kunieda,et al.  Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma , 2014, Journal of gastroenterology and hepatology.

[18]  Jong Hoon Kim,et al.  Stereotactic Body Radiation Therapy as an Alternative Treatment for Small Hepatocellular Carcinoma , 2013, PloS one.

[19]  Zahra Kassam,et al.  Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Ruiliang Ge,et al.  Survival Benefit of Surgical Treatment for Hepatocellular Carcinoma with Inferior Vena Cava/Right Atrium Tumor Thrombus: Results of a Retrospective Cohort Study , 2013, Annals of Surgical Oncology.

[21]  Dong Han Lee,et al.  Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization , 2012, Cancer.

[22]  J. Slater,et al.  The safety and efficacy of high‐dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial , 2011, Cancer.

[23]  A. Koong,et al.  Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. , 2010, International journal of radiation oncology, biology, physics.

[24]  H. Jang,et al.  Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer , 2010, BMC Cancer.

[25]  K. Sung,et al.  Combination of transarterial chemoembolization and three-dimensional conformal radiotherapy for hepatocellular carcinoma with inferior vena cava tumor thrombus. , 2010, International journal of radiation oncology, biology, physics.

[26]  N. Fukumitsu,et al.  A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma. , 2009, International journal of radiation oncology, biology, physics.

[27]  S. Altekruse,et al.  Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  V. Chuang,et al.  Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma with Inferior Vena Cava and Right Atrial Tumors , 2008, CardioVascular and Interventional Radiology.

[29]  K. Saigenji,et al.  Potential Prognostic Benefits of Radiotherapy as an Initial Treatment for Patients with Unresectable Advanced Hepatocellular Carcinoma with Invasion to Intrahepatic Large Vessels , 2008, Oncology.

[30]  Maria Hawkins,et al.  Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  J. Bruix,et al.  Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials , 1999, Hepatology.

[32]  H. Nakahara,et al.  Hepatocellular carcinoma with intra-atrial tumor growth. A clinicopathologic study of 18 autopsy cases. , 1984, Archives of pathology & laboratory medicine.

[33]  A. Jemal,et al.  Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[34]  Jae Hyung Park,et al.  Extrahepatic collateral artery supply to the tumor thrombi of hepatocellular carcinoma invading inferior vena cava: the prevalence and determinant factors. , 2009, Journal of vascular and interventional radiology : JVIR.

[35]  J. Bruix,et al.  Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification , 1999, Seminars in liver disease.